Rafat Abonour
Indiana University Health(US)University of Indianapolis(US)Indiana Cancer Consortium(US)Indiana University Indianapolis(US)Indiana University IndianapolisIndiana University Melvin and Bren Simon Comprehensive Cancer CenterIndiana University School of MedicineIndiana University – Purdue University Indianapolis(US)Indiana University(US)
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors, Peptidase Inhibition and Analysis, Cancer Treatment and Pharmacology, Hematopoietic Stem Cell Transplantation
Most-Cited Works
- → Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial(2009)931 cited
- → Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study(2011)720 cited
- → High-Dose Chemotherapy and Stem-Cell Rescue for Metastatic Germ-Cell Tumors(2007)489 cited
- → Efficient retrovirus-mediated transfer of the multidrug resistance 1 gene into autologous human long-term repopulating hematopoietic stem cells(2000)277 cited
- → A phase 1 trial of the anti-KIR antibody IPH2101 in patients with relapsed/refractory multiple myeloma(2012)237 cited
- → Carfilzomib, pomalidomide, and dexamethasone for relapsed or refractory myeloma(2015)223 cited